in vitro drug screening
Showing 1 - 25 of >10,000
Myeloproliferative Tumor, Secondary Leukemia Trial (Multiomic characterization, In vitro drug screening)
Not yet recruiting
- Myeloproliferative Neoplasm
- Secondary Leukemia
- Multiomic characterization
- In vitro drug screening
- (no location specified)
Aug 28, 2023
Healthy Trial in Philadelphia (Blood draw)
Active, not recruiting
- Healthy
- Blood draw
-
Philadelphia, PennsylvaniaThe Clinical Translational Research Center (CTRC) at the Hospita
Aug 16, 2022
HER2-negative Early Breast Cancer Trial in Beijing (neoadjuvant chemo upon in vitro PTC drug sensitivity screening for triple
Recruiting
- HER2-negative Early Breast Cancer
- neoadjuvant chemotherapy upon in vitro PTC drug sensitivity screening for triple negative breast cancer
- neoadjuvant chemotherapy upon in vitro PTC drug sensitivity screening for luminal like breast cancer
-
Beijing, ChinaPeking University People's Hospital
Mar 27, 2022
HER2-positive Early Breast Cancer Trial in Beijing (neoadjuvant chemo upon in vitro PTC drug sensitivity screenning)
Recruiting
- HER2-positive Early Breast Cancer
- neoadjuvant chemotherapy upon in vitro PTC drug sensitivity screenning
-
Beijing, Beijing, ChinaPeking University People'S Hospital
Mar 28, 2021
Colo-rectal Cancer Trial in Beijing (adjuvant therapy based on 3D drug sensitivity test results of micro tumor (PTC) in vitro)
Recruiting
- Colo-rectal Cancer
- adjuvant therapy based on 3D drug sensitivity test results of micro tumor (PTC) in vitro
-
Beijing, China/Beijing, ChinaPeking Union Medical College Hospital, Chinese Academy of Medici
Aug 4, 2023
Combined Point of Care Diagnostic of HIV, HBV and HCV Trial in Marseille (MagIA IBC test in capillary blood, MagIA IBC test in
Recruiting
- Combined Point of Care Diagnostic of HIV, HBV and HCV
- MagIA IBC test in capillary blood
- MagIA IBC test in other matrices
-
Marseille, FranceHopital Européen de Marseille
Oct 9, 2023
Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma Trial in Houston (Biospecimen Collection, Follow-Up)
Recruiting
- Recurrent Mantle Cell Lymphoma
- Refractory Mantle Cell Lymphoma
- Biospecimen Collection
- Follow-Up
-
Houston, TexasM D Anderson Cancer Center
Dec 5, 2022
Pancreatic Cancer, Gastric Cancer Trial in Hangzhou (Biopsy of tumor tissue for organoid culture)
Recruiting
- Pancreatic Cancer
- Gastric Cancer
- Biopsy of tumor tissue for organoid culture
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital, Zhejiang University School of med
Apr 22, 2023
Drug-resistant Psychiatric Disorders Using Induced Pluripotent
Enrolling by invitation
- Depressive Disorder, Treatment-Resistant
-
Monza, Monza E Brianza, ItalyFondazione IRCCS San Gerardo di Monza
May 24, 2023
Newly Diagnosed Glioblastoma Trial (combinations of up to 3 FDA approved drugs from a panel of compounds)
Not yet recruiting
- Newly Diagnosed Glioblastoma
- combinations of up to 3 FDA approved drugs from a panel of compounds
- (no location specified)
Jan 19, 2023
Infertility Trial in New York (in vitro maturation, Polar Body Biopsy with preimplantation genetic screening)
Recruiting
- Infertility
- in vitro maturation
- Polar Body Biopsy with preimplantation genetic screening
-
New York, New YorkCenter for Reproductive Medicine- Weill Cornell Medical College
Nov 18, 2022
Isolation of Cell Free Fetal DNA From Spent Culture Medium and
Completed
- Females Undergoing PGD Technology for Medical Conditions
- Preimplantation Genetic Screening
-
Damascus, Syrian Arab RepublicDamascus University
Oct 17, 2023
AML Trial in Berne (Image-based ex-vivo drug screening platform (pharmacoscopy))
Recruiting
- AML
- Image-based ex-vivo drug screening platform (pharmacoscopy)
-
Berne, SwitzerlandDepartement of Medical Oncology, University Hospital Berne
Feb 8, 2023
Acute Interstitial Nephritis, Drug-Induced Interstitial Nephritis Trial in Paris (in vitro Allergological test Allergological
Not yet recruiting
- Acute Interstitial Nephritis
- Drug-Induced Interstitial Nephritis
- in vitro Allergological test Allergological skin tests
-
Paris, FranceNephrology department, Tenon hospital - APHP
Jun 29, 2022
Treatment Compliance Trial in Karachi (to evaluate the safety and efficacy of Ansa for the treatment of UTi and control of Ecoli
Recruiting
- Treatment Compliance
- to evaluate the safety and efficacy of Ansa for the treatment of UTi and control of Ecoli infection
-
Karachi, Sindg, Pakistan
- +1 more
Oct 6, 2022
Tissue Collection for Drug Screening and Bioanalysis
Recruiting
- Pediatric Central Nervous System Tumor
- Central Nervous System Tumor
-
New York, New YorkWeill Cornell Medicine
Nov 28, 2022
Potential Research Subjects
Recruiting
- Addiction
-
Baltimore, MarylandNational Institute on Drug Abuse, Biomedical Research Center (BR
Feb 2, 2023
Organoids-on-a-chip for Colorectal Cancer and in Vitro Screening
Recruiting
- Colorectal Neoplasms
- Organoids
- comprehensive treatment after MDT discussion
-
Beijing, ChinaPeking University People's Hospital
Aug 12, 2021
Patient-Specific Genotypes and Phenotypes That Influence Drug
Enrolling by invitation
- Cancer
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 28, 2023
Medulloblastoma, Medulloblastoma, Childhood, Medulloblastoma Recurrent Trial in United States (Specialized Tumor Board Treatment
Recruiting
- Medulloblastoma
- +2 more
- Specialized Tumor Board Treatment Plan
-
San Diego, California
- +3 more
Dec 28, 2022
Colon Cancer, Rectal Cancer, Chemo Effect Trial in Beijing (5-fluorouracil + formyltetrahydrofolate/Oxaliplatin + 5-fluorouracil
Recruiting
- Colon Cancer
- +4 more
- 5-fluorouracil + formyltetrahydrofolate/Oxaliplatin + 5-fluorouracil + formyltetrahydrofolate/Irinotecan + 5-fluorouracil + formyltetrahydrofolate/Cetuximab + 5-fluorouracil + formyltetrahydrofolate
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jun 15, 2022
Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Kidney Cancer Trial in Boston (Implantable Microdevice (IMD))
Not yet recruiting
- Renal Cell Carcinoma
- +2 more
- Implantable Microdevice (IMD)
-
Boston, MassachusettsDana-Farber Cancer Institute
Jan 17, 2023
Human Immunodeficiency Virus (HIV), Hepatitis C (HCV) Trial in New York (Video Format, Health Educator)
Not yet recruiting
- Human Immunodeficiency Virus (HIV)
- Hepatitis C (HCV)
- Video Format
- Health Educator
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Jul 21, 2023
Adenoid Cystic Carcinoma, Adenoid Cystic Carcinoma of the Salivary Gland Trial in Boston (Implantable Microdevice (IMD))
Not yet recruiting
- Adenoid Cystic Carcinoma
- Adenoid Cystic Carcinoma of the Salivary Gland
- Implantable Microdevice (IMD)
-
Boston, Massachusetts
- +1 more
Sep 22, 2022
Community Pharmacy-Based Prescription Drug Monitoring Program
Active, not recruiting
- Opioid Abuse
- Prescription Drug Abuse (Not Dependent)
-
Cincinnati, Ohio
- +1 more
Jun 23, 2022